Status:
UNKNOWN
The Effect Of Heel Protector In Intensive Care Units
Lead Sponsor:
Maltepe University
Conditions:
Pressure Ulcer, Heel
Plantar Flexion Contracture of Tarsometatarsal Joint
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
Purpose: It was aimed to evaluate the effectiveness of using heel protector products for the prevention of heel pressure sore and plantar flexion contracture in patients hospitalized in intensive care...
Eligibility Criteria
Inclusion
- High-risk patients; patients who were intubated or extubated in the ICU for at least 5 days and received sedation
- Patients with Braden Pressure Sore Risk Assessment Scale 16 and below
- Patients with a Ramsey Sedation Scale of 4 and above
Exclusion
- BMI over 30
- Patients with vascular disease
- Patients with albumin level below 2.5 mg/dL
- Patients mobile within 5 days
- Patients hospitalized with heel pressure ulcer
- Despite being included in the study, the patient becomes mobile before 15 days
- Patients with a medical condition that contraindicates the use of heel protectors
Key Trial Info
Start Date :
February 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
84 Patients enrolled
Trial Details
Trial ID
NCT05436340
Start Date
February 1 2022
End Date
December 1 2022
Last Update
November 1 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kübra Arslan
Kocaeli, Turkey (Türkiye)